Search

Search Constraints

You searched for: Author/Creator Kitamura, Hiroshi

Search Results

31. Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study. (21st July 2022)

32. Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors. (11th September 2022)

33. Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer. (22nd September 2020)

37. Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study. (23rd July 2020)

38. Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching. Issue 1 (January 2022)

39. Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma. Issue 5 (June 2021)